HORIZON-MISS-2021-CANCER-02
HORIZON-MISS-2021-CANCER-02
- Programme
- HORIZON
- Funded projects (dataset)
- 12
- EU contribution (sum)
- €125,354,100
- Portal deadline
- —
Leading topic in historical projects: HORIZON-MISS-2021-CANCER-02-01
Start here
Suggested partners for this call
Who coordinated consortia under this call, plus a complementary slice (topic leaders, research partners, or frequent non-coordinators). For industry lists, CSV export, and consortium size — open Proposal partner finder.
Top coordinators
Organisations that coordinated the most funded projects under this call.
- IARC1 coordinated
- RESEARCH UNIVERSITY INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS1 coordinated
- UOA1 coordinated
- EXUS SOFTWARESINGLE MEMBER LIMITED LIABILITY COMPANY1 coordinated
- INT1 coordinated
- TLS1 coordinated
- IDIBAPS-CERCA1 coordinated
- TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY1 coordinated
- TAU1 coordinated
- THERMOMIND LTD1 coordinated
- UKE1 coordinated
- ULB1 coordinated
Organisations strong on this topic
Broader signal: frequent participants across funded projects tagged with the same topic codes as this call (not limited to coordinators).
- GERMAN CANCER RESEARCH CENTER3 topic projects
- MEDICAL UNIVERSITY OF GRAZ3 topic projects
- AINIGMA2 topic projects
- CHUL2 topic projects
- UT2 topic projects
- E.C.O.2 topic projects
- HOPE2 topic projects
- IDIBELL-CERCA2 topic projects
- IRB BARCELONA - CERCA2 topic projects
- ICO2 topic projects
- INSTITUT CURIE FONDATION2 topic projects
Frequent collaborators
Pairs that often appear together in the same funded project under this call.
- 2 shared
- AINIGMA · MEDICAL UNIVERSITY OF GRAZ2 shared
BE ↔ AT
- 2 shared
- MEDICAL UNIVERSITY OF GRAZ · RESEARCH UNIVERSITY INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS2 shared
AT ↔ EL
- INSTITUT CURIE FONDATION · INT2 shared
FR ↔ IT
- 2 shared
- 2 shared
- 2 shared
- 2 shared
- 2 shared
- 2 shared
- 2 shared
- GERMAN CANCER RESEARCH CENTER · INT2 shared
DE ↔ IT
- ICO · IDIBELL-CERCA2 shared
ES ↔ ES
- 1 shared
- 1 shared
- 1 shared
- UMC-Mainz · MEDICAL UNIVERSITY OF GRAZ1 shared
DE ↔ AT
Proposal partner finder
One page with suggested coordinators, strong and industry partners, topic leaders, typical consortium size, similar projects — plus CSV or print / PDF export for your shortlist.
Typical consortium pattern
Derived from historical funded projects linked to this CORDIS call in Grantibase.
- Avg. orgs / project
- 21.08
- Median orgs / project
- 21
- Min / max orgs
- 7 – 40
Country presence
Participant rows (an org can appear in multiple countries if data varies).
- Spain29
- Germany27
- Italy26
- Belgium24
- France20
- Greece16
- Israel15
- Netherlands14
- United Kingdom10
- Sweden8
- Austria7
- Lithuania7
- Cyprus6
- Portugal5
- Romania5
- Switzerland4
- Poland4
- Denmark4
Organization types
- university65 orgs · 78 rows
- research_institute51 orgs · 62 rows
- sme44 orgs · 46 rows
- other25 orgs · 28 rows
- public_body19 orgs · 21 rows
- company18 orgs · 18 rows
Topics in funded projects
- HORIZON-MISS-2021-CANCER-02-01HORIZON-MISS-2021-CANCER-02-01· 6 projects
- HORIZON-MISS-2021-CANCER-02-03HORIZON-MISS-2021-CANCER-02-03· 5 projects
- HORIZON-MISS-2021-CANCER-02-02HORIZON-MISS-2021-CANCER-02-02· 1 projects
Related funded projects
Largest EU contributions in this call — useful to see who already won funding on similar lines.
Open full project list in advanced search
| Project | Programme | EU contribution |
|---|---|---|
| DIOPTRA EARLY DYNAMIC SCREENING FOR COLORECTAL CANCER VIA NOVEL PROTEIN BIOMARKERS REFLECTING BIOLOGICAL INITIATION MECHANISMS | HORIZON | €13,646,551 |
| LUCIA Understanding Lung Cancer related risk factors and their Impact | HORIZON | €13,516,869 |
| ONCOSCREEN A European “shield” against colorectal cancer based on novel, more precise and affordable risk-based screening methods and viable policy pathways | HORIZON | €12,972,076 |
| GENIAL Understanding Gene ENvironment Interaction in ALcohol-related hepatocellular carcinoma | HORIZON | €11,996,753 |
| ThermoBreast An innovative non-contact and harmless screening modality set to change the course of breast cancer detection and patient monitoring | HORIZON | €11,432,044 |
| EUonQoL Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe | HORIZON | €10,607,311 |
| ELMUMY Elucidation of risk factors and health determinants associated with PROGRESSION of Monoclonal Gammopathies to Multiple Myeloma | HORIZON | €9,951,078 |
| PANCAID PANcreatic CAncer Initial Detection via liquid biopsy | HORIZON | €9,838,840 |
| DISCERN Discovering the causes of three poorly understood cancers in Europe | HORIZON | €8,857,813 |
| SANGUINE Early detection and screening of hematological malignancies | HORIZON | €8,478,000 |
| MELCAYA Novel health care strategies for melanoma in children, adolescents and young adults | HORIZON | €8,013,219 |
| MammoScreen Innovative and safe microwave-based imaging technology to make breast cancer screening more accurate, inclusive and female-friendly | HORIZON | €6,043,547 |
